Aktienanalyse zu Chemed Corp (CHE)CHEChemed Corp

Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Chemed Corp is a good buy right now due to its current price of $512.98, which is below the median analyst price target of $549, suggesting a potential upside of 7.1%. Additionally, the forward P/E ratio of 18.18 indicates that the stock is reasonably valued compared to its expected earnings growth. The recent positive analyst coverage and the company's strong revenue growth, with Q2 2026 revenue reported at $673.25 million, support a bullish outlook. However, the main risk is the insider selling activity, with an executive selling 1,000 shares, which could signal caution among insiders.

4 analysts cover CHE: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 547.33.